Bank of America Initiates Coverage on Eurand N.V. (EURX) with a Neutral
EURX Hot Sheet
Rating Summary:1 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 25 | Down: 12 | New: 36
Bank of America initiates coverage on Eurand N.V. (Nasdaq: EURX) with a Neutral rating. Price target $15.
To see more analyst ratings on EURX Click Here.
Eurand N.V., a specialty pharmaceutical company, develops, manufactures, and commercializes pharmaceutical and biopharmaceutical products.
To see more analyst ratings on EURX Click Here.
Eurand N.V., a specialty pharmaceutical company, develops, manufactures, and commercializes pharmaceutical and biopharmaceutical products.
You May Also Be Interested In
- UPDATE: Canaccord Genuity Starts KIT Digital (KITD) at Hold; OTT Video Trends Remain Strong, But Concerns Remain
- Barclays Cuts Price Target and Estimates on NetApp (NTAP); Disappointing Qtr, But There Is Hope
- Stephens Starts Cree (CREE) at Equal Weight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Bank of AmericaSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
